Palisade Bio last closed at $1.46 (+1.39%) on 2026-10-05. Signals today: Death cross. Listed on Nasdaq. Trailing 12 months PER is -9.7×. Its overall grade ranks 182 of 741 stocks in Healthcare.
About this company
Palisade Bio last closed at $1.46 (+1.39%) on 2026-10-05. Signals today: Death cross. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall A- · 182/741
Valuation grade B+
Related stocks
- Aurinia PharmaceuticalsCompetitor
자가면역·염증성 질환 치료제 분야의 바이오의약품 경쟁사
- AmgenCompetitor
면역·염증 질환 치료제 대형 바이오 경쟁사
- AbbVieCompetitor
면역질환 치료제 포트폴리오를 가진 대형 제약 경쟁사
About Palisade Bio
- What technical signals does Palisade Bio (PALI) have?
- Palisade Bio current technical signals: death cross (50_200, 0d ago).
- Is Palisade Bio a cup-and-handle pattern?
- No. Palisade Bio has no valid Cup signal right now.
- What published figures are available for Palisade Bio?
- Market cap: $217.54M. Trailing 12 months PER: -9.7×. Latest quarter PBR: 2.53×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Palisade Bio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy